Dec 07, 2016 13:30 pm UTC| Business
MISSION VIEJO, Calif., Dec. 07, 2016 -- MYnd Analytics, Inc. (OTCQB:MYAN), a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health...
Dec 07, 2016 13:30 pm UTC| Business
MIAMI, Dec. 07, 2016 -- The Female Health Company/Veru Healthcare (NASDAQ:FHCO) today announced its plan for a Phase 2 clinical trial for MSS-722, the company’s proprietary oral drug candidate for the treatment of male...
Capstone Further Cuts Expenses by Reducing External Audit and Investor Relations Expenses
Dec 07, 2016 13:30 pm UTC| Business
CHATSWORTH, Calif., Dec. 07, 2016 -- Capstone Turbine Corporation (www.capstoneturbine.com) (Nasdaq:CPST), the world's leading clean technology manufacturer of microturbine energy systems, announced today that as part...
Dec 07, 2016 13:30 pm UTC| Business
NEW YORK, Dec. 07, 2016 -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and other products for targeting and treating cancer, today announced that the first patient...
Immudyne Announces Definitive Endorsement Agreement with Leading Dermatologist
Dec 07, 2016 13:30 pm UTC| Business
MT. KISCO, N.Y., Dec. 07, 2016 -- ImmuDyne, Inc. (OTCQB:IMMD) (“Immudyne” or the “Company”), a leader in the development and marketing of OTC health and wellness products addressing large unmet needs, today announced...
Mimecast Fuels Market Expansion by Further Extending API Capabilities for MSPs
Dec 07, 2016 13:30 pm UTC| Business
Watertown, MA, Dec. 07, 2016 -- Mimecast Limited (NASDAQ: MIME), a leading email and data security company, today announced a further extension to the Mimecast API, designed to help Managed Service Provider (MSP)...
SteadyMed Hires Pulmonary Hypertension Veteran to Lead Patient Advocacy and Community Relations
Dec 07, 2016 13:30 pm UTC| Business
SAN RAMON, Calif., Dec. 07, 2016 -- SteadyMed Therapeutics Ltd. (NASDAQ:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet...